AXTI - CIK 0001051627
AXT INC trades as AXTI and has a market capitalization of $5.58 B, making it the #1301 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $88.33M, down 11.1% from the prior year and net income of -$21.26M. This page tracks AXT INC through 1,003 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 9 fiscal years AXT INC's revenue grew from $81.35M to $88.33M, a compound annual growth rate of 0.9%. Net profit margin compressed from 6.9% to -24.1% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| SCHEDULE 13G | - | 2026-05-18 |
| Proxy materials | DEFA14A | 2026-05-18 |
| Proxy materials | DEFA14A | 2026-05-15 |
| Major company event | 8-K | 2026-05-15 |
| Quarterly report | 10-Q | 2026-05-14 |
| SCHEDULE 13G/A | - | 2026-05-08 |
| SCHEDULE 13G | - | 2026-05-06 |
| Insider trade | 4 | 2026-05-05 |
AXT, Inc. (Nasdaq: AXTI), a leading manufacturer of compound semiconductor substrates, today announced that it will participate in the upcoming financial conferences:
During the current adjournment, the Company expects to continue to solicit votes from its stockholders with respect to the proposals set forth in the Company’s proxy statement. The Company has engaged a proxy solicitor, Alliance Advisors, to assist management with obtaining adequate votes to achieve the required quorum.
“This is an incredibly exciting time for AXT,” said Morris Young, chief executive officer. “Last week we completed a capital raise for $632.5 million in support of Tongmei’s indium phosphide capacity expansion as well as R&D investment in new products like 6-inch indium phosphide. Indium phosphide substrates are a key ingredient in high-speed optical data transmission required in AI focused data centers. Thanks goes to our investors who are helping us address the strong demand we are seeing. As the market continues to grow, capacity will become a critical enabler. Longer-term capacity planning is one of the most important discussions we are having today with customers and major supply chain players in our space. The message we have for them is this: AXT is stepping up. We believe we are in the best position to support and enable our industry in meeting the current and future needs.”
The largest companies sharing AXT INC's SEC industry classification (semiconductors & related devices).
AXT INC (AXTI) has a market capitalization of $5.58 B as of 2026-06-10, ranking #1301 among US-listed companies.
AXT INC reported revenue of $88.33M for fiscal year 2025, a decrease of 11.1% year over year.
In its latest fiscal year AXT INC reported a net loss of $21.26M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
AXT, Inc. (NasdaqGS: AXTI) (“AXT” or the “Company”), a leading manufacturer of compound semiconductor wafer substrates, announced today that, in connection with its recently completed underwritten public offering of 8,560,311 shares of common stock, the underwriters have exercised their over-allotment option to purchase an additional 1,284,046 shares of common stock at a price to the public of $64.25 for additional gross proceeds of approximately $82.5 million, before deducting underwriting discounts and commissions and other offering expenses.
AXT, Inc. (NasdaqGS: AXTI) (“AXT” or the “Company”), a leading manufacturer of compound semiconductor wafer substrates, announced today the closing of its underwritten public offering of 8,560,311 shares of common stock at a price to the public of $64.25 per share. The Company received total gross proceeds of approximately $550 million, before deducting the underwriting discounts and commissions and other offering expenses. In addition, the Company granted the underwriter a 30-day option to purchase up to 1,284,046 additional shares of common stock at the public offering price, less the underwriting discounts (the “Overallotment Option”). If the Overallotment Option is fully exercised, the Company expects to receive aggregate gross proceeds of approximately $632.5 million, before deducting underwriting discounts and commissions and other offering expenses.